At Pfizer, the certification recognises the company’s Analytics Gateway and broader data science ecosystem, where teams work ...

Shares of Pfizer Inc. PFE rallied 1.71% to $25.58 Wednesday, on what proved to be an all-around poor trading session for the ...

Sanofi Chief Executive Paul Hudson said on Wednesday the company is likely to see some weakness in U.S. vaccine demand this ...

A Covid vaccine researcher claims she was silenced for years right before warning the public about the dangers to certain ...

Eli Lilly leads in the GLP-1 drug space with its shot-based offerings Mounjaro and Zepbound. Rival drugmaker Novo Nordisk has ...

In the latest close session, Pfizer (PFE) was up +1.63% at $25.56. This move outpaced the S&P 500's daily loss of 0.53%. On the other hand, the Dow registered a loss of 0.09%, and the ...

Trump's demand to cap credit card rates at 10% is a crowd-pleaser, but might cause more problems than it solves.

A change of tone from the US authorities has introduced new uncertainties. Under health secretary and outspoken vaccine ...

Novo Nordisk's CEO spoke about GLP-1 pricing and Pfizer's CEO spoke about the company's obesity ambitions while at the ...

Drugmaker CEOs see sales online channels as a budding opportunity, while some biotech investors told BioPharma Dive to expect ...

In this week’s edition of InnovationRx, we look at a ‘holy grail’ pill for sleep apnea, Pomelo Care’s expansion, Nvidia and ...

FAYETTEVILLE, NY, UNITED STATES, January 9, 2026 /EINPresswire.com/ — January is traditionally a peak period for pharmaceutical list price adjustments. The AnalySource team analyzed Wholesale ...